Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Efficacy and safety analysis of different dose idarubicin plus cytarabine regimen as induction chemotherapy for young patients with de-novo acute myeloid leukemia].
Zhang Y, Yao XM, Zhu SL, Suo SS, Mao LP, Wei JY, Yu WJ, Mai WY, Tong HY, Meng HT, Qian WB, Jin J. Zhang Y, et al. Among authors: qian wb. Zhonghua Xue Ye Xue Za Zhi. 2016 Aug 14;37(8):682-7. doi: 10.3760/cma.j.issn.0253-2727.2016.08.010. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27587250 Free PMC article. Clinical Trial. Chinese.
[Intermediate-high dose cytarabine consolidation therapy in younger adults with acute myeloid leukemia and favorable-intermediate cytogenetic risk: a retrospective study of 124 patients in a single Chinese hospital].
Zhang Y, Qian JJ, Wang L, Yu WJ, Mao LP, Tong HY, Meng HT, Qian WB, Jin J. Zhang Y, et al. Among authors: qian wb, qian jj. Zhonghua Xue Ye Xue Za Zhi. 2019 May 14;40(5):429-431. doi: 10.3760/cma.j.issn.0253-2727.2019.05.016. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31207711 Free PMC article. Chinese. No abstract available.
[Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
Ge T, Liu H, Wang ZH, Cao Y, Zhang YC, Huang L, Qian WB, Zhou XX. Ge T, et al. Among authors: qian wb. Zhonghua Xue Ye Xue Za Zhi. 2023 Oct 14;44(10):825-831. doi: 10.3760/cma.j.issn.0253-2727.2023.10.006. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38049334 Free PMC article. Chinese.
286 results